EuResist Network GEIE is a European Economic Interest Grouping composed by:
- Karolinska Institutet (Stockholm, Sweden)
- Max Planck Institute for Informatics (Saarbrücken, Germany)
- University of Siena (Italy)
- InformaPRO s.r.l. (Rome, Italy)
- Cologne University (Germany).
The EuResist Network is a nonprofit partnership with the following objectives:
- to promote joint research and scientific projects on behalf of its Members;
- to coordinate the dissemination and exploitation of the results derived from the EuResist project and from the other activities of the Grouping.
EuResist Network is continously expanding with new partners in Europe and in the world. Partnership is based on mutual scientific collaboration and data sharing. The Network is seeking for financial support from different private and public sources in order to carry on its activities and to provide free services to the public.
EuResist-Arevir Annual Meeting - Programme
Cologne, 29-30 April 2016
For registration and accommodation: Claudia.Mueller@med.uni-duesseldorf.de
EuResist in Kurdistan
Erbil, 24-29 February 2016
During the second mission of the KRG SHMS Project, the pilot monitoring system has been installed in 10 test centres in Erbil, Dohuk and Suleymania.
EuResist Engine updated
The EuResist Engine has been retrained to predict response after 48 weeks from treatmennt start, on a database of more than 66.000 patients. Performance is 0.73 - 0.76 AUC
EucoHIV accepts study proposals!
The EucoHIV Project collected around 1605 datasets of patients on Maraviroc treatment. The data are now open for research proposals. Visit the EucoHIV website
EuResist at ISPOR 2014
Amsterdam - 10 November 2014
Francesca Incardona presented the Euresist experience to an audience of more than 800 people within the educational symposium on "Big data, advanced analytics and the transformation of health care delivery" at the ISPOR 17th annual European congress.
EuResist-Arevir annual meeting
Cologne April 4-5, 2014
The Programme of the EuResist session and the slides of the meeting are available online!
26 March 2014
The training on HIV coreceptor was held Wednesday March 26th from 10.00 till 12.00 in the Fira Palace Hotel, Barcelona. For the programme, please see at: upcoming trainings
EuResist "Success Story" is now in a book
EuREsist project success story and Francesca Incardona's interview for the 16th issue of the SME update are now published in the publication Investing in European Success.
EDCTP ENNEA Annual Meeting
24 October 2012, Nairobi, Kenya
The International Management Board meeting of the Project, sustained by EuResist Network, will be hosted by World Friends Kenya.
EuResist at the International Woman Child and HIV Congress
8-10 October 2012, St. Petersburg, Russia
EuResist Network is invited to present its history and initiatives.
Phylogenetics on large clinical HIV resistance databases
30 August 2012, Belgrade, Serbia
EuResist has been presented at the workshop organised by UniLeuven within the 17th International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology
EuResist International Meeting
May 4 2012
within the AREVIR-GenaFor meeting 2012 in Cologne. Talks on EuResist present and future, EuResist in Africa, the EucoHIV project, the EuResist engine in Brasil: a comparative study, History-alignment models.
EuResist Network at the sixth EDCTP Forum
October 9-12 Addis Ababa, Ethiopia
Supporting the EDCTP ENNEA project, EuResist Network was at the sixth EDCTP Forum (link www.edctpforum.org) where a poster has been presented. On the 13th the II IMB meeting has been held at Black Lyon Hospital, Addis.
AIDS Research Award
The AIDS Research Award of the Heinz-Ansmann Foundation to Rolf Kaiser, Thomas Lengauer and Mark Oette for interdisciplinary team work in HIV resistance analysis that laid the ground for improved patient care. 11 February 2011
2010 - 2011: IBM international campaigns are based on EuResist
EuResist Network received the prestigious Computerworld Honors program laureate Award
June 1, 2009, Washington, D.C.
In addition to it, EuResist also won the 21st Century Achievement award, establishing its technology contribution as top of its class among the Healthcare Laureates.